Gliadel

Gliadel is a brand name of carmustine, approved by the FDA in the following formulation(s):

GLIADEL (carmustine - implant; intracranial)

• 
  Manufacturer: EISAI INC
  
  Approval date: September 23, 1996
  
  Strength(s): 7.7MG ^[RLD]

Has a generic version of Gliadel been approved?

No. There is currently no therapeutically equivalent version of Gliadel available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Gliadel. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Gliadel.

See also...

• Gliadel Implant Wafer Consumer Information (Wolters Kluwer)
• Gliadel Consumer Information (Cerner Multum)
• Gliadel Advanced Consumer Information (Micromedex)
• Carmustine Consumer Information (Wolters Kluwer)
• Carmustine Implant Wafer Consumer Information (Wolters Kluwer)
• Carmustine Consumer Information (Cerner Multum)
• Carmustine Implantation Advanced Consumer Information (Micromedex)
• Carmustine Intravenous Advanced Consumer Information (Micromedex)
• Carmustine AHFS DI Monographs (ASHP)